Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-118570
Filing Date
2024-10-30
Accepted
2024-10-30 06:17:06
Documents
25

Document Format Files

Seq Description Document Type Size
1 424B3 lxeo_424b3_20241030.htm 424B3 48763
2 EX-99.1 lxeo-ex99_1.htm EX-99.1 36111
3 EX-99.2 lxeo-ex99_2.htm EX-99.2 26857
4 GRAPHIC img46940271_0.jpg GRAPHIC 249664
5 GRAPHIC img95183645_0.jpg GRAPHIC 5674
6 GRAPHIC lxeo-ex99_2s1.jpg GRAPHIC 272301
7 GRAPHIC lxeo-ex99_2s2.jpg GRAPHIC 548612
8 GRAPHIC lxeo-ex99_2s3.jpg GRAPHIC 363196
9 GRAPHIC lxeo-ex99_2s4.jpg GRAPHIC 462469
10 GRAPHIC lxeo-ex99_2s5.jpg GRAPHIC 345196
11 GRAPHIC lxeo-ex99_2s6.jpg GRAPHIC 475871
12 GRAPHIC lxeo-ex99_2s7.jpg GRAPHIC 324195
13 GRAPHIC lxeo-ex99_2s8.jpg GRAPHIC 465802
14 GRAPHIC lxeo-ex99_2s9.jpg GRAPHIC 478237
15 GRAPHIC lxeo-ex99_2s10.jpg GRAPHIC 370407
16 GRAPHIC lxeo-ex99_2s11.jpg GRAPHIC 311896
17 GRAPHIC lxeo-ex99_2s12.jpg GRAPHIC 313259
18 GRAPHIC lxeo-ex99_2s13.jpg GRAPHIC 418864
19 GRAPHIC lxeo-ex99_2s14.jpg GRAPHIC 308884
20 GRAPHIC lxeo-ex99_2s15.jpg GRAPHIC 445093
21 GRAPHIC lxeo-ex99_2s16.jpg GRAPHIC 313012
22 GRAPHIC lxeo-ex99_2s17.jpg GRAPHIC 274875
23 GRAPHIC lxeo-ex99_2s18.jpg GRAPHIC 423038
24 GRAPHIC lxeo-ex99_2s19.jpg GRAPHIC 477437
25 GRAPHIC lxeo-ex99_2s20.jpg GRAPHIC 148096
  Complete submission text file 0000950170-24-118570.txt   10848562
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278566 | Film No.: 241407266
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)